STAND. COM. REP. NO. 2128

Honolulu, Hawaii

RE: S.B. No. 2033

S.D. 1

Honorable Ronald D. Kouchi

President of the Senate

Thirty-First State Legislature

Regular Session of 2022

State of Hawaii

Sir:

Your Committee on Health, to which was referred S.B. No. 2033 entitled:

"A BILL FOR AN ACT RELATING TO THE ELECTRONIC PRESCRIPTION ACCOUNTABILITY SYSTEM,"

begs leave to report as follows:

The purpose and intent of this measure is to require that the dispensing of a pharmacist-prescribed opioid antagonist be reported to the State's Electronic Prescription Accountability System (System).

Your Committee received testimony in support of this measure from the Department of Health and Department of Public Safety. Your Committee received comments on this measure from Kaiser Permanente Hawaii.

Your Committee finds that Act 255, Session Laws of Hawaii 2019, authorized pharmacists to issue prescriptions for opioid-antagonists, thereby increasing access to lifesaving drugs. Although pharmacists are required to report the dispensation of certain controlled substances to the System, they are not required to report opioid antagonist prescriptions. This measure requires pharmacists to report prescriptions for opioid antagonists to the System, providing the Department of Health with valuable data to help prevent opioid overdose.

Your Committee has amended this measure by making technical, nonsubstantive amendments for the purposes of clarity and consistency.

As affirmed by the record of votes of the members of your Committee on Health that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 2033, as amended herein, and recommends that it pass Second Reading in the form attached hereto as S.B. No. 2033, S.D. 1, and be referred to your Committee on Judiciary.

Respectfully submitted on behalf of the members of the Committee on Health,

________________________________

JARRETT KEOHOKALOLE, Chair